A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The division cycle of eukaryotic cells is regulated by a family of protein kinases known as the cyclin-dependent kinases (CDKs). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The complexes formed by CDK4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. CDK4 exists, in part, as a multi-protein complex with a D-type cyclin, proliferating cell nuclear antigen and a protein, p21 (refs 7-9). CDK4 associates separately with a protein of M(r) 16K, particularly in cells lacking a functional retinoblastoma protein. Here we report the isolation of a human p16 complementary DNA and demonstrate that p16 binds to CDK4 and inhibits the catalytic activity of the CDK4/cyclin D enzymes. p16 seems to act in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p16, on the other hand, acts through the Retinoblastoma (Rb) pathway (Serrano et al, 1993).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Serrano et al, 1993
In the citing paper
“p16INK4A is a 16 KDa protein that directly binds to CDK4/6 and blocks the formation of cyclinD-CDK4/6 complexes, thereby preventing phosphorylation of RB and promoting expression of E2F target genes (Serrano et al., 1993).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Serrano et al., 1993
In the citing paper
“This member of the INK4a family is a cyclin D-dependent kinase CDK4 and CDK6 inhibitor, which prevents the phosphorylation of the retinoblastoma protein (Rb), therefore leading to suspension of the cell cycle before the S-phase [78,79].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [78]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,114
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationSherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationFunctional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
A family of human cdc2-related protein kinases.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., & Tsai, L. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 923
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Research works printed but not linked: 2
- Motokura, T. & Arnold, A. Biochim. biophys. Acta 1155, 63–78 (1993).
- Lukas, J., Pagano, M., Staskova, Z., Draetta, G. & Bartek, J. Oncogene (in the press).
Cited by
Items 801–900 of 1,022
P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2
Xirodimas, D. P., Chisholm, J., Desterro, J. M. S., Lane, D. P., & Hay, R. T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03310-0 · Cited by 94
MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway
Sheikh, B. N., Phipson, B., El-Saafin, F., Vanyai, H. K., Downer, N. L., Bird, M., Kueh, A. J., May, R. E., Smyth, G. K., Voss, A. K., et al. (2015) · Oncogene · doi:10.1038/onc.2015.33 · Cited by 98
Islet biology, the CDKN2A/B locus and type 2 diabetes risk
Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016) · Diabetologia · doi:10.1007/s00125-016-3967-7 · Cited by 104
“hypophosphorylated Rb represses early region 2 transcription factor (E2F) to prevent cell cycle entry [74].”
Re, M., Gioacchini, F. M., Bajraktari, A., Tomasetti, M., Kaleci, S., Rubini, C., Bertini, A., Magliulo, G., & Pasquini, E. (2017) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-017-4571-2 · Cited by 93
“which controls the crucial G1–S phase transition [20, 21].”
Ishikawa, M., Fujii, T., Saito, M., Nindl, I., ONO, A., Kubushiro, K., Tsukazaki, K., Mukai, M., & NOZAWA, S. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00355.x · Cited by 105
Omelyanenko, V. G., Gentry, C. A., Kopečková, P., & Kopec̆ek, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980209)75:4<643::aid-ijc24>3.0.co;2-8 · Cited by 92
Klangby, U., Okan, İ., Magnússon, K. P., Wendland, M., Lind, P., & Wiman, K. G. (1998) · Blood · doi:10.1182/blood.v91.5.1680 · Cited by 106
Serological evidence of an association betweenChlamydia pneumoniae infection and lung cancer
Laurila, A. L., Anttila, T., Läärä, E., Bloigu, A., Virtamo, J., Albanes, D., Leinonen, M., & Saikku, P. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<31::aid-ijc6>3.0.co;2-1 · Cited by 138
Zhang, W., Kornblau, S. M., Kobayashi, T., Gambel, A. M., Claxton, D. F., & Deisseroth, A. B. (1995) · PubMed · Cited by 107
Cell cycle regulators in bladder cancer: A multivariate survival study with emphasis, on p27Kip1
Korkolopoulou, P. A., Christodoulou, P., Konstantinidou, A. E., Thomas-Tsagli, E., Kapralos, P., & Davaris, P. (2000) · Human Pathology · doi:10.1053/hupa.2000.8227 · Cited by 98
Interaction of Cyclin-dependent Kinase 5 (Cdk5) and Neuronal Cdk5 Activator in Bovine Brain
Lee, K., Rosales, J. L., Tang, D., & Wang, J. H.-C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1538 · Cited by 92
Taniai, M., Higuchi, H., Burgart, L. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36021 · Cited by 99
Oikawa, S., Furukawa, A., Asada, H., Hirakawa, K., & Kawanishi, S. (2003) · Free Radical Research · doi:10.1080/1071576031000150751 · Cited by 93
“Two fragments containing exon 1 or 2 of the human p16 tumor suppressor gene([27]) were obtained as described previously.”
MethodFunk, J. O., Schiller, P. I., Barrett, M. T., Wong, D. J., Kind, P., & Sander, C. A. (1998) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1998.tb01748.x · Cited by 104
Genomic instability and cancer
Tlsty, T. D., Briot, A., Gualberto, A., Hall, I. J., Hess, S. M., Hixon, M. L., Kuppuswamy, D., Romanov, S., Sage, M., & White, A. (1995) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(95)00016-d · Cited by 93
Ghaneh, P., Greenhalf, W., Humphreys, M. J., Wilson, D., Zumstein, L. A., Lemoine, N. R., & Neoptolemos, J. P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301394 · Cited by 100
Temperature-Sensitive Mutants of p16CDKN2 Associated with Familial Melanoma
Parry, D., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3844 · Cited by 94
“DISCUSSION The only known function of p16CDKN2 is to bind to Cdk4 and Cdk6 and thereby inhibit their activity as Cdks (15, 41, 48).”
BackgroundInfluentialThe clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
Gao, D., Herman, J. G., & Guo, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7949 · Cited by 102
“Therefore, the cell cycle is disrupted by P16 methylation and the cell number in the S-phase is increased.”
BackgroundRole of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines
Sartor, M., Steingrimsdottir, H., Elamin, F., Gäken, J. A., Warnakulasuriya, S., Partridge, M., Thakker, N., Johnson, N. W., & Tavassoli, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690505 · Cited by 103
“…families be p16/CDKN2/MTS1 (Serrano et al, 1993) and p21/WAF1/CI respectively. p21/WAF1 is thought to be a ‘universal’ CDK inhibiting the activity of both Cyclin D-CDK4/6 and Cyclin E CDK2 complexes (Xiong et al, 1993) while p16/MTS1 on inhibits cyclin D1-CDK4/6 complexes (Serrano et al, 1993).”
BackgroundDai, C. Y., Furth, E. E., Mick, R., Koh, J., Takayama, T., Niitsu, Y., & Enders, G. H. (2000) · Gastroenterology · doi:10.1053/gast.2000.17952 · Cited by 92
“We then used IHC to identify whether p16 ]NK4a expression (1) was observed in neoplastic cells or stromal cells of the tumors; (2) occurred in early stages of neoplasia, for which tissue quantity often limits use of immunoprecipitation-Western blot and RT-PCR; (3) correlated with histologic features of dysplasia, diff…”
MethodThe Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
García-Reyes, B., Kretz, A.-L., Ruff, J.-P., von Karstedt, S., Hillenbrand, A., Knippschild, U., Henne‐Bruns, D., & Lemke, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103219 · Cited by 101
“CDK4/6-cyclin D-associated hyperphosphorylation of Rb is prevented and consequently S-phase entry through suppression of E2F-mediated transcription [154,158].”
BackgroundParallel global profiling of plant TOR dynamics reveals a conserved role for LARP1 in translation
Scarpin, M. R., Leiboff, S., & Brunkard, J. O. (2020) · eLife · doi:10.7554/elife.58795 · Cited by 101
“In this canonical pathway, D-type cyclins bind to and activate cyclin-dependent kinases that phosphorylate and thus inactivate Retinoblastoma-related RBR1, derepressing E2F transcription factors that drive the transcriptional program of the G1/S phase cellcycle transition (Ach et al., 1997; Choi and Anders, 2014; Ebel…”
BackgroundTherapeutic Strategies for Targeting CDKN2A Loss in Melanoma
Kreuger, I. Z. M., Slieker, R. C., van Groningen, T., & van Doorn, R. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.07.016 · Cited by 120
Tsuda, H., YAMAMOTO, K., Inoue, T., Uchiyama, I., & Umesaki, N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0980 · Cited by 95
Comparative Histopathology of Grey‐Horse‐Melanoma and Human Malignant Melanoma
Seltenhammer, M. H., Heere‐Ress, E., Brandt, S., Druml, T., Jansen, B., Pehamberger, H., & NIEBAUER, G. W. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00192.x · Cited by 91
Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines
Park, Y.-B., Park, M. J., Kimura, K., Shimizu, K., Lee, S. H., & Yokota, J. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00575-1 · Cited by 100
Irreversibility of cellular senescence: dual roles of p16INK4a/Rb-pathway in cell cycle control
Takahashi, A., Ohtani, N., & Hara, E. (2007) · Cell Division · doi:10.1186/1747-1028-2-10 · Cited by 91
“The INK4a gene encodes another type of CDK inhibitor, p16INK4a, which specifically binds to and inactivates Dtype CDKs, CDK4 and CDK6 [41].”
BackgroundKröger, N. M., Milde‐Langosch, K., Riethdorf, S., Schmoor, C., Schumacher, M. C., Zander, A. R., & Löning, T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1340 · Cited by 106
p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer
Kawamoto, K., Enokida, H., Gotanda, T., Kubo, H., Nishiyama, K., Kawahara, M., & Nakagawa, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.072 · Cited by 92
Ogawa, N., Noguchi, K.-I., Sawai, H., Yamashita, Y., Yompakdee, C., & Oshima, Y. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.997 · Cited by 90
Update on familial cancer syndromes and the skin
Tsao, H. (2000) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2000.104681 · Cited by 98
D‐type cyclins repress transcriptional activation by the v‐Myb but not the c‐Myb DNA‐binding domain
Ganter, B., Fu, S., & Lipsick, J. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.255 · Cited by 100
“Furthermore, the kinase inhibitor p16INK4 (Serrano et al., 1993) did not affect the cyclin D-specific repression of v-Myb.”
BackgroundExpression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic Lesions
Keller‐Melchior, R., Schmidt, R. A., & Piepkorn, M. W. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00211.x · Cited by 96
“A full-length recombinant bacterially produced GST-p16INK4 fusion protein was used as immunogen for preparation of the antip16INK4 antibody (Serrano et al, 1993).”
BackgroundMethodChironna, M., Calabrò, M. L., Quarto, M., Germinario, C. A., Fiore, J. R., Favero, A., Potenza, D., Chieco‐Bianchi, L., & Barbuti, S. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960315)65:6<778::aid-ijc12>3.0.co;2-0 · Cited by 7
Regulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 102
Bacterial induction of B cell senescence promotes age-related changes in the gut microbiota
Kawamoto, S., Uemura, K., Hori, N., Takayasu, L., Konishi, Y., Katoh, K., Matsumoto, T., Suzuki, M., Sakai, Y., Matsudaira, T., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01145-5 · Cited by 91
Lee, K., Adhikary, G., Balasubramanian, S., Gopalakrishnan, R., McCormick, T. S., Dimri, G. P., Eckert, R. L., & Rorke, E. A. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700949 · Cited by 97
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript et al., 1993). p19arf (p14arf in humans) prevents the degradation and inactivation of the p53 tumor suppressor protein by binding to MDM2 (Serrano et al., 1993;Weber et al., 1999).”
BackgroundSequential Unfolding of Ankyrin Repeats in Tumor Suppressor p16
Tang, K. S., Fersht, A. R., & Itzhaki, L. S. (2003) · Structure · doi:10.1016/s0969-2126(02)00929-2 · Cited by 105
Zhang, J.-Y., Megliorino, R., Peng, X.-X., Tan, E. M., Chen, Y., & Chan, E. K. L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.010 · Cited by 93
“P16 protein is a cyclin-dependent kinase (CDK) inhibitor, which plays an important role in the regulation of the cell cycle by inactivating the cyclin-dependent kinase (CDK) that phosphorylates retinoblastoma (Rb) protein [31].”
BackgroundDong, Y., Sui, L., Sugimoto, K., Tai, Y., & Tokuda, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4<209::aid-ijc1036>3.0.co;2-r · Cited by 93
Genetic mechanisms in squamous cell carcinoma of the head and neck
Jefferies, S., & Foulkes, W. D. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00065-8 · Cited by 89
Fotedar, R., Diederich, L., & Fotedar, A. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_15 · Cited by 95
Ramalingam, A., Hirai, A. M., & Thompson, E. A. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.5.9923 · Cited by 96
Arendt, T. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00216-5 · Cited by 97
Venkataramani, R. N., Swaminathan, K., & Marmorstein, R. (1998) · Nature Structural Biology · doi:10.1038/nsb0198-74 · Cited by 89
Characterization of ligurian melanoma families and risk of occurrence of other neoplasia
Ghiorzo, P., Ciotti, P., Mantelli, M., Heouaine, A., Queirolo, P., Rainero, M. L., Ferrari, C., Santi, P. L., De Marchi, R., Farris, A., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<441::aid-ijc2>3.0.co;2-r · Cited by 88
Wang, C., Li, Z., Fu, M., Bouras, T., & Pestell, R. G. (2004) · Cancer treatment and research · doi:10.1007/1-4020-7847-1_11 · Cited by 100
p16INK4A Represses the paracrine tumor-promoting effects of breast stromal fibroblasts
Al‐Ansari, M. M., Hendrayani, S., Shehata, A. I., & Aboussekhra, A. (2012) · Oncogene · doi:10.1038/onc.2012.270 · Cited by 92
Vo, Q. N., Geradts, J., Gulley, M. L., Boudreau, D. A., Bravo, J. C., & Schneider, B. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.9.669 · Cited by 88
2,4,6-Trinitrotoluene-induced Reproductive Toxicity via Oxidative DNA Damage by its Metabolite
Homma‐Takeda, S., Hiraku, Y., Ohkuma, Y., Oikawa, S., Murata, M., Ogawa, K., Iwamuro, T., Li, S., Sun, G. F., Kumagai, Y., et al. (2002) · Free Radical Research · doi:10.1080/10715760290025933 · Cited by 90
“DNA fragments were obtained from the human c-Ha-ras-1 protooncogene([21]) and the tumor suppressor genes, p16([22]) and p53.”
MethodDeng, Z., Hasegawa, M., Kiyuna, A., Matayoshi, S., Uehara, T., Agena, S., Yamashita, Y., Ogawa, K., Maeda, H., & Suzuki, M. (2012) · Head & Neck · doi:10.1002/hed.23034 · Cited by 91
“Functional inactivation of pRb by E7 is known to induce an upregulation of p16 expression.(13,14) These 2 oncoproteins are consistently expressed in high-risk HPV infection, which implies that they play a role in the initiation and/or progression of tumors,(15) and their cooperative interaction may lead to substantial…”
BackgroundChromosomal imbalances and partial uniparental disomies in primary central nervous system lymphoma
Schwindt, H., Vater, I., Kreuz, M., Montesinos‐Rongen, M., Brunn, A., Richter, J., Gesk, S., Ammerpohl, O., Wiestler, O. D., Hasenclever, D., et al. (2009) · Leukemia · doi:10.1038/leu.2009.120 · Cited by 88
“44 P16, that is, one of the encoded proteins, specifically inhibits CDK4 and CDK6 and potentially blocks G1 cell-cycle progression through the dephosphorylation of retinoblastoma through its inhibitory effect on the CDK4scyclin D1 complex activity”
BackgroundLorenz, S., Barøy, T., Sun, J., Nome, T., Vodák, D., Bryne, J.-C., Håkelien, A.-M., Fernandez-Cuesta, L., Möhlendick, B., Rieder, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6567 · Cited by 88
“In the tumor cohort we identified 5 samples harboring rearrangements in or around the RB1 locus, with 4 samples containing translocations (2 in intron 2, 1 in intron 7, 1 in intron 21) and one sample with a 2.7 Mb deletion covering the whole gene.”
BackgroundInfluentialVascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation
Mistriotis, P., & Andreadis, S. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.006 · Cited by 92
Allelotype of endometrial carcinoma.
Fujino, T., Risinger, J. I., Collins, N. K., Liu, F.-S., Nishii, H., Takahashi, H., Westphal, E., Barrett, J. C., Sasaki, H., & Kohler, M. F. (1994) · PubMed · Cited by 94
Estanyol, J. M., Jaumot, M., Casanovas, O., Rodriguez-Vilarrupla, A., Agell, N., & Bachs, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33161 · Cited by 88
Park, M., & Krause, M. (1999) · Development · doi:10.1242/dev.126.21.4849 · Cited by 101
Negative regulation of cell growth by TGFβ
Polyák, K. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00009-5 · Cited by 106
Chen, Z., Guo, Y., Zhao, D., Zou, Q., Yu, F., Zhang, L., & Xu, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.808208 · Cited by 87
Cudré-Mauroux, C., Occhiodoro, T., König, S., Salmon, P., Bernheim, L., & Trono, D. (2003) · Human Gene Therapy · doi:10.1089/104303403322495034 · Cited by 87
“…(Jacobs et al ., 1999). p16 blocks cell cycle progression by inhibiting cyclin D-dependent kinases and thereby prevents the phosphorylation of Rb (Serrano et al ., 1993), whereas p19arf prevents the degradation and inactivation of p53 by binding to Mdm2 (Pomerantz et al ., 1998; Weber et al .,…”
Quiescence regulators for hematopoietic stem cell
Li, J. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.01.008 · Cited by 108
Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer
Jarmalaitė, S., Kannio, A., Anttila, S. L., Lazutka, J. R., & Husgafvel‐Pursiainen, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11322 · Cited by 100
Fuxe, J., Akusjärvi, G., Goike, H. M., Roos, G., Collins, V. P., & Pettersson, R. F. (2000) · PubMed · Cited by 99
Samper, E., Goytisolo, F. A., Murcia, J. M.-D., González-Suárez, E., Cigudosa, J. C., de Murcia, G., & Blasco, M. A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200103049 · Cited by 87
“As control for the two-hybrid assay we show interaction between the cell cycle proteins CDK4 and p16 as described previously (Table VI; Serrano et al., 1993).”
MethodPancreatic Carcinoma Surveillance in Patients With Familial Melanoma
Parker, J. F. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.8.1019 · Cited by 89
“Mutations in the CDKN2A gene allow cells to bypass the G1/S cell cycle checkpoint, leading to uncontrolled cell proliferation and growth.(11-14) Mutations in the CDKN2A gene are found in approximately 20% to 40% of melanomaprone families(1,2,12) and are associated with the familial atypical multiple mole melanoma synd…”
BackgroundKato, D., Miyazawa, K., Ruas, M., Starborg, M., Wada, I., Oka, T., Sakai, T., Peters, G., & Hara, E. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00426-8 · Cited by 87
David-Pfeuty, T. (1999) · Oncogene · doi:10.1038/sj.onc.1203103 · Cited by 96
“Senescent cells also express enhanced levels of wt p53 and p16INKa, a Cdk4-speci®c inhibitor, (Atadja et al., 1995; Alcorta et al., 1996; Rezniko et al., 1996; Hara et al., 1996; Xiong et al., 1993a; Serrano et al., 1993).”
BackgroundCDKN2A (p16INK4A) somatic and germline mutations
Smith-Sørensen, B., & Hovig, E. (1996) · Human Mutation · doi:10.1002/(sici)1098-1004(1996)7:4<294::aid-humu2>3.0.co;2-9 · Cited by 87
APOPTOSIS OF CRYPT EPITHELIAL CELLS IN ULCERATIVE COLITIS
IWAMOTO, M., KOJI, T., MAKIYAMA, K., KOBAYASHI, N., & NAKANE, P. K. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199610)180:2<152::aid-path649>3.0.co;2-y · Cited by 312
The genetics of melanoma: recent advances
Hill, V. K., Gartner, J. J., Samuels, Y., & Goldstein, A. M. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153429 · Cited by 86
Replicative senescence revisited.
Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86
“p16 INK4a was discovered as a cdk4-interacting protein that inhibits the catalytic activity of cdk4–cyclin D complexes (17), and then it emerged as a major tumor suppressor when it was found to be mutated in a large variety of human cancers, such as lung and brain cancer; melanoma, glioma, kidney, bladder, and ovary c…”
BackgroundKobayashi, H., Oikawa, S., Hirakawa, K., & Kawanishi, S. (2004) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2003.11.002 · Cited by 88
Oxidative damage to cellular and isolated DNA by homocysteine: implications for carcinogenesis
Oikawa, S., Murakami, K., & Kawanishi, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206440 · Cited by 85
“Preparation of 32P-labeled DNA fragments from the c-Ha-ras-1, p53, and p16 genes DNA fragments were obtained from the human p53 (Chumakov, 1990) and p16 (Serrano et al., 1993) tumor suppressor genes, and the c-Ha-ras-1 proto-oncogene (Capon et al., 1983).”
BackgroundMolecular Biology of Human Oral Cancer
Wong, D. T., Todd, R., Tsuji, T., & Donoff, R. B. (1996) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411960070040201 · Cited by 98
“A tumor suppressor gene (TSG) initially isolated from melanoma cells, pl6 (MTS1 or CDKN2), is also found in this region and may prove to be a cell-cycle inhibitor important in oral cancer development (Serrano and Hannon, 1993; Kambetal, 1994; Van der Riet et al, 1994).”
The role of transforming growth factor Β in glioma progression
Jennings, M. T., & Pietenpol, J. A. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005863419880 · Cited by 99
Tamura, G. (2004) · PubMed · doi:10.14670/hh-19.221 · Cited by 86
“…the catalytic activity of the CDK4/cyclin D enzymes, and acts in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein (Serrano et al., 1993). p16 is frequently inactivated by homozygous deletion or promoter hypermethylation in many types of human cancers (Herman et…”
BackgroundKashiwabara, K., Oyama, T., Sano, T., Fukuda, T., & Nakajima, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980619)79:3<232::aid-ijc4>3.0.co;2-q · Cited by 85
Genetic and Epigenetic Changes in Mammary Epithelial Cells May Mimic Early Events in Carcinogenesis
Tlsty, T. D., Crawford, Y., Holst, C. R., Fordyce, C., Zhang, J., McDermott, K. M., Kozakiewicz, K., & Gauthier, M. L. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048773.95897.5f · Cited by 89
“The p16INK4a gene product was initially isolated by two-hybrid screening for proteins associated with cyclin dependent kinase 4 (20), and was found to be a member of a family of proteins that bind and block the activity of cyclin D/cdk4 complexes and induce cell cycle arrest.”
Calbó, J., Parreño, M., Sotillo, E., Yong, T., Mazo, A., Garriga, J., & Graña, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209181200 · Cited by 94
p16INK4A adenovirus-mediated gene therapy for human head and neck squamous cell cancer.
Rocco, J. W., Li, D., Liggett, W. H., Duan, L., Saunders, J. K., Sidransky, D., & O'Malley, B. W. (1998) · PubMed · Cited by 86
Ageing as developmental decay: insights from p16INK4a.
Martin, N., Beach, D., & Gil, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.09.008 · Cited by 76
Self-citationJerome‐Majewska, L. A., Jenkins, G. P., Ernstoff, E., Zindy, F., Sherr, C. J., & Papaioannou, V. E. (2005) · Developmental Dynamics · doi:10.1002/dvdy.20575 · Cited by 85
“The p16 protein blocks the enzymatic activities of cyclin D-dependent kinases (Serrano et al., 1993), whereas p19 (p14 in humans) inhibits the p53 negative regulator, Mdm2, thereby inducing a p53 transcriptional program that leads to cell cycle arrest or apoptosis (Kamijo et al.”
BackgroundMolecular Analysis of the 9p21 Locus and p53 Genes in Ewing Family Tumors
López‐Guerrero, J. A., Pellín, A., Noguera, R., Cardá, C., & Llombart‐Bosch, A. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780290 · Cited by 89
“Among these CDKI are p16INK4A (MTS1, CDKN2) (Kamb et al, 1994; Serrano et al, 1993) and p15INK4B (MTS2) (Hannon and Beach, 1994), which form binary complexes exclu- sively with CDK4 and CDK6, inhibiting their function and, by so doing, inhibiting pRb phosphorylation during G1 (Graña and Reddy,…”
BackgroundCell cycle profiles and expressions of p21CIP1 and p27KIP1 during myocyte development
Poolman, R. A., Gilchrist, R., & Brooks, G. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00320-9 · Cited by 93
Prognostic Role ofE2F1and Members of theCDKN2ANetwork in Gastrointestinal Stromal Tumors
Haller, F., Gunawan, B., von Heydebreck, A., Schwager, S., Schulten, H.-J., Wolf-Salgó, J., Langer, C., Ramadori, G. P., Sültmann, H., & FÜZESI, L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0329 · Cited by 101
The significant role of telomerase activity in human brain tumors
Nakatani, K., Yoshimi, N., Mori, H., Yoshimura, S.-I., Sakai, H., Shinoda, J., & Sakai, N. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3<421::aid-cncr10>3.0.co;2-z · Cited by 50
Tsuji, S., Minami, S., Hashimoto, R., Konishi, Y., Suzuki, T., Kondo, T., Sasai, M., Torii, S., Ono, C., Shichinohe, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00170-7 · Cited by 84
Wittekindt, C., G�ltekin, E., Weissenborn, S. J., Dienes, H. P., Pfister, H., & Klußmann, J. P. (2004) · KARGER eBooks · doi:10.1159/000082474 · Cited by 97
Kim, J. S., Kim, J. W., Han, J., Shim, Y. M., Park, J., & Kim, D.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3813 · Cited by 84
“The p16 protein inhibits cell cycle progression through G1 into S phase, past the G1 checkpoint by maintaining the retinoblastoma protein in an unphosphorylated state (10, 11).”
BackgroundThe p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light
Almohanna, M., Al‐Khalaf, H. H., Al‐Yousef, N., & Aboussekhra, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1075 · Cited by 92
Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus
Park, W., Vortmeyer, A. O., Pack, S., Duray, P. H., Böni, R., Guerami, A. A., Emmert‐Buck, M. R., Liotta, L. A., & Zhuang, Z. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90221-0 · Cited by 87
Modulation of Cell Cycle Components by Epigenetic and Genetic Events
Macaluso, M., Montanari, M., Cinti, C., & Giordano, A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.009 · Cited by 95
Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato, A., Zhang, Y. J., Arber, N., Hibshoosh, H. H., Doki, Y., Ciaparrone, M., Santella, R. M., Cittadini, A. R. M., & Weinstein, I. B. (1997) · PubMed · Cited by 95
Urano, T., Yashiroda, H., Muraoka, M., Tanaka, K., Hosoi, T., Inoue, S., Ouchi, Y., Tanaka, K., & Toyoshima, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12197 · Cited by 89
Induction of mammary gland hyperplasia in transgenic mice over-expressing human Cdc25B
Ma, Z.-Q., Chua, S. S., DeMayo, F. J., & Tsai, S. Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202809 · Cited by 89
“On the other hand, CKIs of the INK4 family, which include p15, p16, p18, and p19, are selective for complexes consisting of the D-type cyclins and cdk4 or cdk6 (Hirai et al., 1995; Serrano et al., 1993).”
BackgroundOhnishi, H., Kawamura, M., Ida, K., Sheng, X., Hanada, R., Nobori, T., Yamamori, S., & Hayashi, Y. (1995) · Blood · doi:10.1182/blood.v86.4.1269.bloodjournal8641269 · Cited by 84
Targeted Therapies for Pancreatic Cancer
Amanam, I. U., & Chung, V. M. (2018) · Cancers · doi:10.3390/cancers10020036 · Cited by 92
“This CDK4/6 hyperac vation then leads o inactivation of the RB tum suppressor leadi g to additional proliferation [9,11].”
BackgroundInfluentialXaus, J., Valledor, A. F., Cardó, M., Marquès, L., Beleta, J., Palacios, J. M., & Celada, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4140 · Cited by 83
Liang, J.-T., Chang, K.-J., Chen, J.-C., Lee, C.-C., Cheng, Y.-M., Hsu, H.-C., Wu, M.-S., Wang, S.-M., Lin, J.-T., & Cheng, A.-L. (1999) · Oncology · doi:10.1159/000012023 · Cited by 83
Metadata
- Authors
- Serrano, M., Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1993-12
- Volume
- 366
- Issue
- 6456
- Pages
- 704-707
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066848701
- Cited by
- 3,650
- References
- 22
- Citations by year
- 2026: 36 · 2025: 46 · 2024: 52 · 2023: 66 · 2022: 67 · 2021: 78 · 2020: 64 · 2019: 63 · 2018: 56 · 2017: 70 · 2016: 69 · 2015: 75 · 2014: 52 · 2013: 98 · 2012: 88
- FWCI
- 78.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p16, CDK4, cyclin D, cyclin-dependent kinases, cell cycle regulation, G1 phase, kinase inhibition, retinoblastoma protein, p21, proliferating cell nuclear antigen, feedback regulation, cell proliferation
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cloning, Molecular, DNA, Glutathione Transferase, HeLa Cells, Humans, Molecular Sequence Data, Phosphorylation, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Saccharomyces cerevisiae, Oncogene Proteins, Retinoblastoma Protein, Cyclins, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors, Cyclin-Dependent Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.